OXFORD NANOPORE TECHNOLOGIES PLC

Ajouter à une liste

Communiqués Oxford Nanopore Technologies plc

Actions

ONT

GB00BP6S8Z30

Equipement et technologie médicale avancés

Marché Fermé - London S.E. Autres places de cotation 17:35:05 17/06/2026			Varia. 5j.	Varia. 1 janv.
117,80 ^GBX	-0,84%		-6,43%	-8,26%

21/05	Tungsten s'assure un prêt ; Ashtead confirme ses objectifs	AN
21/05	Oxford Nanopore Technologies nomme ses directeurs médicaux et de l'information	MT

Communiqués

12/06	Institut Pasteur de Dakar Sequences the First Human Whole Genomes in the Country and Launches an Early Cancer Detection Platform [press release]	AQ
01/05	Oxford Nanopore Technologies : Proxy Form for 2026 AGM	PU
09/10/25	Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032	PR
02/09/25	Oxford Nanopore Technologies : Interim results for the 6 months ended 30 June 25	PU
07/08/25	ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology	BU
10/06/24	Oxford Nanopore Technologies : Result of AGM	PU
01/11/23	Oxford Nanopore Technologies and Fabric Genomics collaborate to launch an integrated whole-genome sequencing solution to advance the future of paediatric patient care	AQ
31/10/23	Oxford Cannabinoid Technologies Holdings plc	AQ
26/10/23	Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing	AQ
12/06/23	Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing	AQ
14/04/23	Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics	BU
22/03/23	Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market	AQ
20/03/23	Oxford Nanopore and 4bases announce collaboration to combine nanopore sequencing devices and 4bases kits to support rapid, high-accuracy analyses in human and cancer genetics	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Bourse
Actions
Action ONT
Actualités Oxford Nanopore Technologies plc
Communiqués

DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !

PROFITEZ-EN MAINTENANT